US5622871A
(en)
|
1987-04-27 |
1997-04-22 |
Unilever Patent Holdings B.V. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
US4997772A
(en)
*
|
1987-09-18 |
1991-03-05 |
Eastman Kodak Company |
Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
|
DE3856421T2
(de)
|
1987-04-27 |
2000-12-14 |
Unilever Nv |
Spezifische Bindungstestverfahren
|
US5194300A
(en)
*
|
1987-07-15 |
1993-03-16 |
Cheung Sau W |
Methods of making fluorescent microspheres
|
IT1217993B
(it)
*
|
1988-02-01 |
1990-03-30 |
Boehringer Biochemia Srl |
Metodo analitico impiegante reagneti biospecifici marcati con macromolecole colorate
|
JPH01214760A
(ja)
*
|
1988-02-23 |
1989-08-29 |
Teikoku Hormone Mfg Co Ltd |
免疫学的簡易測定方法
|
US5145784A
(en)
*
|
1988-05-04 |
1992-09-08 |
Cambridge Biotech Corporation |
Double capture assay method employing a capillary flow device
|
US5252459A
(en)
*
|
1988-09-23 |
1993-10-12 |
Abbott Laboratories |
Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
|
FR2638848B1
(fr)
*
|
1988-11-04 |
1993-01-22 |
Chemunex Sa |
Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
|
US6352862B1
(en)
|
1989-02-17 |
2002-03-05 |
Unilever Patent Holdings B.V. |
Analytical test device for imuno assays and methods of using same
|
US5547839A
(en)
|
1989-06-07 |
1996-08-20 |
Affymax Technologies N.V. |
Sequencing of surface immobilized polymers utilizing microflourescence detection
|
CA2016999A1
(en)
*
|
1989-07-19 |
1991-01-19 |
Sunil G. Anaokar |
Assay method and apparatus
|
DE69017471D1
(de)
*
|
1990-02-22 |
1995-04-06 |
Univ Mcgill |
Feststoff-phase-interferometrisches immunotestsystem.
|
CA2088195A1
(en)
*
|
1990-08-31 |
1992-03-01 |
David C. Horwell |
Cholecystokinin antagonists, their preparation and therapeutic use
|
US5266497A
(en)
*
|
1990-08-31 |
1993-11-30 |
Japan Synthetic Rubber Co., Ltd. |
Immunochromatographic assay with improved colored latex
|
JP2628792B2
(ja)
*
|
1990-09-26 |
1997-07-09 |
アカーズ・リサーチ・コーポレーシヨン |
改良されたリガンドのアッセイ
|
JPH0737990B2
(ja)
*
|
1990-10-12 |
1995-04-26 |
寳酒造株式会社 |
糖類の標識方法及び糖類標識用キット
|
US5192510A
(en)
*
|
1991-01-30 |
1993-03-09 |
E. I. Du Pont De Nemours And Company |
Apparatus for performing fluorescent assays which separates bulk and evanescent fluorescence
|
FR2673292A1
(fr)
*
|
1991-02-26 |
1992-08-28 |
Sebia Sa |
Procede d'immunofixation ou d'immunoelectrophorese a l'aide d'un ensemble d'au moins deux immunserums differents ou deux solutions d'immunoglobulines differentes et kit pour la mise en óoeuvre d'un tel procede.
|
WO1992020746A1
(en)
*
|
1991-05-14 |
1992-11-26 |
Hybritech, Incorporated |
Polymeric compositions having bound antibodies
|
US5998220A
(en)
|
1991-05-29 |
1999-12-07 |
Beckman Coulter, Inc. |
Opposable-element assay devices, kits, and methods employing them
|
US6168956B1
(en)
|
1991-05-29 |
2001-01-02 |
Beckman Coulter, Inc. |
Multiple component chromatographic assay device
|
US5877028A
(en)
|
1991-05-29 |
1999-03-02 |
Smithkline Diagnostics, Inc. |
Immunochromatographic assay device
|
US5395754A
(en)
*
|
1992-07-31 |
1995-03-07 |
Hybritech Incorporated |
Membrane-based immunoassay method
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
BE1006245A3
(fr)
*
|
1993-05-03 |
1994-06-14 |
Ape Associates As |
Reactifs pour la detection ou le dosage d'un analyte dans un echantillon, trousses les contenant, et procede de detection ou de dosage utilisant ces reactifs.
|
US5352585A
(en)
*
|
1993-06-29 |
1994-10-04 |
Bio-Rad Laboratories, Inc. |
System for benzodiazepine detection
|
GB2314333B
(en)
*
|
1993-10-05 |
1998-04-29 |
Asahi Optical Co Ltd |
Antigen or antibody immobilised on dyed composite comprising polymer granules coated with a calcium phosphate
|
CH686518A5
(de)
*
|
1993-10-05 |
1996-04-15 |
Asahi Optical Co Ltd |
Granulares Polymerkomposit, Herstellungsverfahren fur dieses und diagnostische Mittel.
|
CA2167362A1
(en)
*
|
1995-02-10 |
1996-08-11 |
Alexei Dmitri Klimov |
Apparatus and method for conducting a binding assay on an absorbent carrier material
|
EP0873363B1
(de)
|
1995-06-14 |
2010-10-06 |
The Regents of The University of California |
Hochaffine humane antikörper gegen tumorantigene
|
US7455964B1
(en)
|
1996-07-15 |
2008-11-25 |
The Hospital For Sick Children |
Genes from the 20q13 amplicon and their uses
|
US6586193B2
(en)
*
|
1996-04-25 |
2003-07-01 |
Genicon Sciences Corporation |
Analyte assay using particulate labels
|
EP1021554B1
(de)
|
1996-04-25 |
2007-03-21 |
Genicon Sciences Corporation |
Teilchenförmiges markierungsmittel verwendendes analytassay
|
DE19621312A1
(de)
|
1996-05-28 |
1997-12-04 |
Bayer Ag |
Maskierung der Hintergrundfluoreszenz und Signalverstärkung bei der optischen Analyse biologisch medizinischer Assays
|
CN102021153B
(zh)
|
1996-10-01 |
2016-05-25 |
杰龙公司 |
人类的端粒酶催化亚单位
|
US5879951A
(en)
|
1997-01-29 |
1999-03-09 |
Smithkline Diagnostics, Inc. |
Opposable-element assay device employing unidirectional flow
|
AU737406B2
(en)
|
1997-02-07 |
2001-08-16 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Activity dependent neurotrophic factor III (ADNF III)
|
US5981296A
(en)
*
|
1997-02-18 |
1999-11-09 |
Dade Behring Inc. |
Stabilization of particle reagents
|
US6103536A
(en)
|
1997-05-02 |
2000-08-15 |
Silver Lake Research Corporation |
Internally referenced competitive assays
|
US5939252A
(en)
|
1997-05-09 |
1999-08-17 |
Lennon; Donald J. |
Detachable-element assay device
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
US7713703B1
(en)
|
2000-11-13 |
2010-05-11 |
Biosite, Inc. |
Methods for monitoring the status of assays and immunoassays
|
US6194222B1
(en)
*
|
1998-01-05 |
2001-02-27 |
Biosite Diagnostics, Inc. |
Methods for monitoring the status of assays and immunoassays
|
US6265163B1
(en)
|
1998-01-09 |
2001-07-24 |
Lynx Therapeutics, Inc. |
Solid phase selection of differentially expressed genes
|
US6764830B1
(en)
|
1998-01-23 |
2004-07-20 |
The Regents Of The University Of California |
Thermomyces lanuginosus kinesin motor protein and methods of screening for modulators of kinesin proteins
|
US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
US7640083B2
(en)
|
2002-11-22 |
2009-12-29 |
Monroe David A |
Record and playback system for aircraft
|
US20020015957A1
(en)
|
2000-04-29 |
2002-02-07 |
Hageman Gregory S. |
Diagnostics and therapeutics for macular degeneration-related disorders
|
AU762944B2
(en)
*
|
1999-06-23 |
2003-07-10 |
Cornell Research Foundation Inc. |
Dehydration/rehydration of marked liposomes on a test device
|
US6703248B1
(en)
*
|
1999-12-15 |
2004-03-09 |
Dade Behring Marburg Gmbh |
Particles for diagnostic and therapeutic use
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
DE10042023C2
(de)
*
|
2000-08-08 |
2003-04-10 |
Biognostic Ag |
Kapseln, die feste Teilchen signalerzeugender Substanzen einkapseln, und deren Verwendung bei Bioassays zum Nachweis von Zielmolekülen in einer Probe
|
GB0021303D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Medinnova Sf |
Use
|
US7186521B2
(en)
*
|
2000-09-25 |
2007-03-06 |
The Regents Of The University Of California |
Determining the effect of a substance on sequestration, uptake, and accumulation of amyloid in brain cells
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
US7691645B2
(en)
*
|
2001-01-09 |
2010-04-06 |
Agilent Technologies, Inc. |
Immunosubtraction method
|
JP2005507489A
(ja)
*
|
2001-02-23 |
2005-03-17 |
ジェニコン サイエンスィズ コーポレーション |
検体分析において拡張ダイナミックレンジを提供する方法
|
EP2327985B2
(de)
|
2001-06-26 |
2019-08-21 |
Senomyx, Inc. |
Hetero-oligomere T1R-Geschmacksrezeptoren und diese Rezeptoren exprimierende Zelllinien und deren Verwendung zur Identifizierung von Geschmacksverbindungen
|
JP4265149B2
(ja)
*
|
2001-07-25 |
2009-05-20 |
セイコーエプソン株式会社 |
電気光学装置、電気光学装置の製造方法
|
US7300633B2
(en)
|
2001-07-25 |
2007-11-27 |
Oakville Hong Kong Company Limited |
Specimen collection container
|
US7270959B2
(en)
|
2001-07-25 |
2007-09-18 |
Oakville Hong Kong Company Limited |
Specimen collection container
|
CA2461844C
(en)
|
2001-09-27 |
2011-04-05 |
Pioneer Hi-Bred International, Inc. |
Phytate polynucleotides and methods of use
|
US20030099621A1
(en)
|
2001-11-29 |
2003-05-29 |
Robert Chow |
Stem cell screening and transplantation therapy for HIV infection
|
US8367013B2
(en)
|
2001-12-24 |
2013-02-05 |
Kimberly-Clark Worldwide, Inc. |
Reading device, method, and system for conducting lateral flow assays
|
US20030119203A1
(en)
|
2001-12-24 |
2003-06-26 |
Kimberly-Clark Worldwide, Inc. |
Lateral flow assay devices and methods for conducting assays
|
US6837171B1
(en)
|
2002-04-29 |
2005-01-04 |
Palmer/Snyder Furniture Company |
Lightweight table with unitized table top
|
EP1485461A4
(de)
*
|
2002-02-21 |
2005-06-22 |
Eastern Virginia Med School |
Protein-biomarker, die prostatakrebs von nichtmalignen zellen unterscheiden
|
US20030162178A1
(en)
*
|
2002-02-25 |
2003-08-28 |
O'hagan David |
Variable microarray and methods of detecting one or more anlaytes in a sample
|
ATE478337T1
(de)
|
2002-05-31 |
2010-09-15 |
Cornell Res Foundation Inc |
Methoden zum nachweis analyten in proben
|
EP2436774A3
(de)
|
2002-08-01 |
2012-06-13 |
The Regents of The University of California |
Therapeutische monoklonale Antikörper zur Neutralisierung von Botulinumneurotoxinen
|
CA2746000C
(en)
|
2002-08-23 |
2014-10-21 |
Bayer Schering Pharma Aktiengesellschaft |
Biomarkers for diagnosing alzheimer's disease
|
US7285424B2
(en)
*
|
2002-08-27 |
2007-10-23 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based assay devices
|
US7432105B2
(en)
|
2002-08-27 |
2008-10-07 |
Kimberly-Clark Worldwide, Inc. |
Self-calibration system for a magnetic binding assay
|
US7314763B2
(en)
*
|
2002-08-27 |
2008-01-01 |
Kimberly-Clark Worldwide, Inc. |
Fluidics-based assay devices
|
US7883899B2
(en)
*
|
2002-10-11 |
2011-02-08 |
Zbx Corporation |
Diagnostic devices
|
US20040106190A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Kimberly-Clark Worldwide, Inc. |
Flow-through assay devices
|
US20040121334A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Kimberly-Clark Worldwide, Inc. |
Self-calibrated flow-through assay devices
|
US7247500B2
(en)
|
2002-12-19 |
2007-07-24 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in membrane-based assay devices
|
JP2006512075A
(ja)
*
|
2002-12-31 |
2006-04-13 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
イヌcyp1a2配列
|
WO2004058938A2
(en)
*
|
2002-12-31 |
2004-07-15 |
Pharmacia & Upjohn Company Llc |
Canine l-pbe sequences
|
WO2004057940A2
(en)
*
|
2002-12-31 |
2004-07-15 |
Pharmacia & Upjohn Company Llc |
Canine dioxin/aryl hydrocarbon receptor sequences
|
US7560272B2
(en)
|
2003-01-04 |
2009-07-14 |
Inverness Medical Switzerland Gmbh |
Specimen collection and assay container
|
US6977079B2
(en)
*
|
2003-01-17 |
2005-12-20 |
Regents Of The University Of Minnesota |
Avian pneumovirus vaccine
|
EP1594900A2
(de)
*
|
2003-02-14 |
2005-11-16 |
Salmedix, Inc. |
Zusammensetzungen und verfahren zum nachweis und zur behandlung methylthioadenosinphosphorylase-defizienter krebse
|
US7851209B2
(en)
*
|
2003-04-03 |
2010-12-14 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in assay devices
|
US20040197819A1
(en)
|
2003-04-03 |
2004-10-07 |
Kimberly-Clark Worldwide, Inc. |
Assay devices that utilize hollow particles
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
KR20060041179A
(ko)
*
|
2003-06-12 |
2006-05-11 |
박스젠 인코포레이티드 |
비정상적인 이황화물 구조를 지닌 hiv-1 외피 당단백질
|
US20050014734A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Genovate Biotechnology Co., Ltd. |
Modulation of interleukin-10 by DHEA
|
US6914106B2
(en)
*
|
2003-07-23 |
2005-07-05 |
Eastman Kodak Company |
Polymer microspheres containing latent colorants and method of preparation
|
US20050019214A1
(en)
*
|
2003-07-23 |
2005-01-27 |
Eastman Kodak Company |
Colorable polymeric particles with biological probes
|
US7476399B2
(en)
|
2003-08-06 |
2009-01-13 |
Senomyx Inc. |
Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
|
US7517495B2
(en)
|
2003-08-25 |
2009-04-14 |
Inverness Medical Switzerland Gmbh |
Biological specimen collection and analysis system
|
US20050079484A1
(en)
*
|
2003-10-10 |
2005-04-14 |
Heineman William Richard |
Method of detecting biological materials in liquid
|
EP2339024B1
(de)
|
2003-10-21 |
2014-12-31 |
Orion Genomics, LLC |
Verfahren zur quantitativen Bestimmung der Methylierungsdichte in einem DNA-Locus
|
US20050112703A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based lateral flow assay devices that utilize phosphorescent detection
|
US7943395B2
(en)
|
2003-11-21 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Extension of the dynamic detection range of assay devices
|
US7713748B2
(en)
|
2003-11-21 |
2010-05-11 |
Kimberly-Clark Worldwide, Inc. |
Method of reducing the sensitivity of assay devices
|
EP2204385A1
(de)
|
2003-11-25 |
2010-07-07 |
The Government Of U.S.A, As Represented By Secretary, Department of Health and Human Sevices |
Mutanten des Exotoxin A von Pseudomonas und deren Verwendungen
|
US7943089B2
(en)
|
2003-12-19 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Laminated assay devices
|
US20050141843A1
(en)
*
|
2003-12-31 |
2005-06-30 |
Invitrogen Corporation |
Waveguide comprising scattered light detectable particles
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
DK1734970T3
(en)
|
2004-03-12 |
2015-02-16 |
Intercept Pharmaceuticals Inc |
Treatment of fibrosis using FXR ligands
|
CA2955027A1
(en)
|
2004-04-15 |
2005-11-10 |
University Of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
WO2005107796A2
(en)
|
2004-04-23 |
2005-11-17 |
Pharmacia & Upjohn Company, Llc |
Cellular permissivity factor for viruses, and uses thereof
|
US7939251B2
(en)
|
2004-05-06 |
2011-05-10 |
Roche Molecular Systems, Inc. |
SENP1 as a marker for cancer
|
KR20070028547A
(ko)
*
|
2004-06-18 |
2007-03-12 |
리전츠 오브 더 유니버스티 오브 미네소타 |
바이러스에 감염되고 백신접종된 생물의 동정
|
US20080268426A1
(en)
*
|
2004-06-18 |
2008-10-30 |
Regents Of The University Of Minnesota |
Identifying virally infected and vaccinated organisms
|
US8415298B2
(en)
|
2004-06-21 |
2013-04-09 |
The Board Of Trustees Of The Leland Stanford Junior University Of Stanford |
Administration of FGF2 for treamtent of anxiety
|
US7521226B2
(en)
|
2004-06-30 |
2009-04-21 |
Kimberly-Clark Worldwide, Inc. |
One-step enzymatic and amine detection technique
|
US7510858B2
(en)
*
|
2004-08-02 |
2009-03-31 |
Janssen Pharmaceutica N.V. |
IRAK 1c splice variant and its use
|
WO2006023312A2
(en)
*
|
2004-08-20 |
2006-03-02 |
Carl Deirmengian |
Diagnostic assay for source of inflammation
|
US7893197B2
(en)
*
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
WO2006047417A2
(en)
|
2004-10-21 |
2006-05-04 |
University Of Florida Research Foundation, Inc. |
Detection of cannabinoid receptor biomarkers and uses thereof
|
EP2586456B1
(de)
|
2004-10-29 |
2016-01-20 |
ratiopharm GmbH |
Umformung und GlycoPEGylierung des Fibroblastenwachstumsfaktors (FGF)
|
JP2008528060A
(ja)
|
2005-01-27 |
2008-07-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ボツリヌス神経毒素を中和する治療的モノクローナル抗体
|
WO2006107846A2
(en)
|
2005-04-01 |
2006-10-12 |
University Of Florida Research Foundation, Inc. |
Biomakers of liver injury
|
US8048638B2
(en)
*
|
2005-04-01 |
2011-11-01 |
University Of Florida Research Foundation, Inc. |
Biomarkers of liver injury
|
EP3796003A1
(de)
|
2005-04-04 |
2021-03-24 |
Biogen MA Inc. |
Verfahren zur bewertung einer immunreaktion auf ein therapeutisches mittel
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
CA3128824A1
(en)
|
2005-06-24 |
2007-01-04 |
Regents Of The University Of Minnesota |
Prrs viruses, infectious clones, mutants thereof, and methods of use
|
US7642086B2
(en)
|
2005-08-09 |
2010-01-05 |
Canon Kabushiki Kaisha |
Labeled probe bound object, method for producing the same and method for using the same
|
EP1939637A4
(de)
|
2005-09-01 |
2011-02-23 |
Murata Manufacturing Co |
Verfahren und einrichtung zur messung des streukoeffizienten eines untersuchten
|
US8193328B2
(en)
*
|
2005-09-08 |
2012-06-05 |
Philadelphia Health & Education Corporation |
Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
WO2007053524A2
(en)
*
|
2005-10-28 |
2007-05-10 |
The Florida International University Board Of Trustees |
Horse: human chimeric antibodies
|
AU2006311661B2
(en)
|
2005-11-07 |
2011-05-26 |
The Scripps Research Institute |
Compositions and methods for controlling tissue factor signaling specificity
|
EP2564864B8
(de)
|
2005-11-12 |
2015-05-13 |
The Board of Trustees of The Leland Stanford Junior University |
Verfahren im Zusammenhang mit FGF2 zur Diagnose und Behandlung von Depressionen
|
US9056291B2
(en)
|
2005-11-30 |
2015-06-16 |
Micronics, Inc. |
Microfluidic reactor system
|
US7763453B2
(en)
|
2005-11-30 |
2010-07-27 |
Micronics, Inc. |
Microfluidic mixing and analytic apparatus
|
CA2634797A1
(en)
|
2005-12-22 |
2007-07-05 |
Abbott Laboratories |
Methods and marker combinations for screening for predisposition to lung cancer
|
US9347945B2
(en)
|
2005-12-22 |
2016-05-24 |
Abbott Molecular Inc. |
Methods and marker combinations for screening for predisposition to lung cancer
|
WO2007080597A2
(en)
|
2006-01-16 |
2007-07-19 |
Compugen Ltd. |
Polynucleotide and polypeptide sequences and methods for diagnosis
|
PT2676967T
(pt)
|
2006-02-28 |
2019-09-27 |
Biogen Ma Inc |
Métodos para tratamento de doenças inflamatórias e autoimunes com natalizumab
|
CA2644110A1
(en)
|
2006-03-03 |
2007-09-13 |
Elan Pharmaceuticals, Inc. |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
CN105152940A
(zh)
|
2006-04-21 |
2015-12-16 |
西诺米克斯公司 |
含有高效鲜味调料的可食用组合物及其制备方法
|
EP2041573B1
(de)
*
|
2006-06-23 |
2019-09-04 |
PerkinElmer Health Sciences, Inc. |
Verfahren und vorrichtung für mikrofluidische point-of-care-immunoassays
|
WO2008021954A2
(en)
*
|
2006-08-09 |
2008-02-21 |
Biogen Idec Ma Inc. |
Method for distribution of a drug
|
US7569396B1
(en)
|
2006-09-08 |
2009-08-04 |
Purplecow Llc |
Caffeine detection using internally referenced competitive assays
|
US7919331B2
(en)
*
|
2006-12-21 |
2011-04-05 |
Silver Lake Research Corporation |
Chromatographic test strips for one or more analytes
|
WO2008118324A2
(en)
|
2007-03-26 |
2008-10-02 |
Macrogenics, Inc. |
Composition and method of treating cancer with an anti-uroplakin ib antibody
|
US7572990B2
(en)
*
|
2007-03-30 |
2009-08-11 |
Intermec Ip Corp. |
Keypad overlay membrane
|
CN103694351A
(zh)
|
2007-06-05 |
2014-04-02 |
耶鲁大学 |
受体酪氨酸激酶抑制剂及其使用方法
|
AU2008289857B2
(en)
*
|
2007-08-23 |
2014-06-05 |
Phc Corporation |
Use of non-specific reaction inhibitor
|
ES2719728T3
(es)
|
2007-09-04 |
2019-07-12 |
Compugen Ltd |
Polipéptidos y polinucleótidos, y usos de los mismos como una diana farmacológica para producir fármacos y agentes biológicos
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
AU2009258038A1
(en)
*
|
2008-03-14 |
2009-12-17 |
Eastern Virginia Medical School |
Imaging mass spectrometry for improved prostate cancer diagnostics
|
US8993231B2
(en)
*
|
2008-03-18 |
2015-03-31 |
Marshall University Research Corporation |
Methods for stem cell production and therapy
|
AU2009231991B2
(en)
|
2008-04-02 |
2014-09-25 |
Macrogenics, Inc. |
HER2/neu-specific antibodies and methods of using same
|
EP2252631B1
(de)
|
2008-04-02 |
2016-04-13 |
MacroGenics, Inc. |
Bcr-komplex-spezifische antikörper und verfahren zu ihrer verwendung
|
WO2010033279A2
(en)
|
2008-06-04 |
2010-03-25 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
US20100021472A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Geetha Srikrishna |
Methods for diagnosing and treating cancer
|
US9511085B2
(en)
|
2008-08-18 |
2016-12-06 |
Medicinal Bioconvergence Research Center |
Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase
|
WO2010061393A1
(en)
|
2008-11-30 |
2010-06-03 |
Compugen Ltd. |
He4 variant nucleotide and amino acid sequences, and methods of use thereof
|
WO2010065867A1
(en)
|
2008-12-04 |
2010-06-10 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for enhanced yield by targeted expression of knotted1
|
AU2009325878B2
(en)
|
2008-12-08 |
2014-01-16 |
Compugen Ltd. |
TMEM154 polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
TW201039841A
(en)
|
2009-03-27 |
2010-11-16 |
Gojo Ind Inc |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
GB2470939A
(en)
|
2009-06-10 |
2010-12-15 |
Dna Supernova Ltd |
Signal amplification microspheres
|
ES2581178T3
(es)
|
2009-07-29 |
2016-09-01 |
Pharnext |
Nuevas herramientas de diagnóstico para enfermedad de Alzheimer
|
WO2011044553A1
(en)
|
2009-10-11 |
2011-04-14 |
Biogen Idec Ma Inc. |
Anti-vla-4 related assays
|
WO2011067711A2
(en)
|
2009-12-01 |
2011-06-09 |
Compugen Ltd |
Novel heparanase splice variant
|
BR112012017014B1
(pt)
|
2010-01-11 |
2021-07-20 |
Biogen Ma Inc |
Métodos para detecção de anticorpos de vírus jc
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
US9682132B2
(en)
|
2010-01-26 |
2017-06-20 |
Banyan Biomarkers, Inc |
Compositions and methods relating to argininosucccinate synthetase
|
CN102740976B
(zh)
|
2010-01-29 |
2016-04-20 |
精密公司 |
取样-应答微流体盒
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
WO2011106738A2
(en)
|
2010-02-25 |
2011-09-01 |
Fred Hutchinson Cancer Research Center |
Use of tcr clonotypes as biomarkers for disease
|
EP2544688B1
(de)
|
2010-03-02 |
2016-09-07 |
President and Fellows of Harvard College |
Verfahren und zusammensetzungen zur behandlung des angelman-syndroms
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US8383580B2
(en)
|
2010-06-10 |
2013-02-26 |
The Regents Of The University Of Michigan |
Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
|
WO2011163401A2
(en)
|
2010-06-22 |
2011-12-29 |
Neogenix Oncology, Inc. |
Colon and pancreas cancer specific antigens and antibodies
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
WO2012028697A1
(en)
|
2010-09-01 |
2012-03-08 |
Eth Zürich, Institute Of Molecular Biology And Biophysics |
Affinity purification system based on donor strand complementation
|
US8999335B2
(en)
|
2010-09-17 |
2015-04-07 |
Compugen Ltd. |
Compositions and methods for treatment of drug resistant multiple myeloma
|
ES2719624T3
(es)
|
2010-09-23 |
2019-07-11 |
Prec Biologics Inc |
Peptidomiméticos de cáncer de colon y de páncreas
|
WO2012099576A1
(en)
|
2011-01-18 |
2012-07-26 |
Baxter International Inc. |
Measurement of anti-amyloid antibodies in human blood
|
EP2477032A1
(de)
|
2011-01-18 |
2012-07-18 |
Baxter International Inc |
Messung von Antiamyloid-Antikörper in Menschenblut
|
EP2694975A1
(de)
|
2011-04-08 |
2014-02-12 |
Biogen Idec MA Inc. |
Prädiktive biomarker für das therapeutische ansprechen auf ifnbeta und ihre verwendung
|
AU2012241373B2
(en)
|
2011-04-15 |
2016-06-09 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
|
TWI560200B
(en)
|
2011-05-25 |
2016-12-01 |
Innate Pharma Sa |
Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
|
AU2012275841A1
(en)
|
2011-06-27 |
2014-01-16 |
The Jackson Laboratory |
Methods and compositions for treatment of cancer and autoimmune disease
|
CA2836855C
(en)
|
2011-06-30 |
2020-07-14 |
Compugen Ltd. |
Polypeptides and uses thereof for treatment of autoimmune disorders and infection
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
SG2014012728A
(en)
|
2011-08-23 |
2014-06-27 |
Foundation Medicine Inc |
Novel kif5b-ret fusion molecules and uses thereof
|
WO2013043012A2
(en)
*
|
2011-09-22 |
2013-03-28 |
Medicinal Bioconvergence Research Center |
Novel use of leucyl trna synthetase
|
CN104136123B
(zh)
|
2012-01-09 |
2017-03-01 |
精密公司 |
微流体反应器系统
|
EP2807271B1
(de)
|
2012-01-24 |
2018-08-22 |
CD Diagnostics, Inc. |
System zum nachweis einer infektion in der synovialflüssigkeit
|
CN104185681A
(zh)
|
2012-02-01 |
2014-12-03 |
卡姆普根有限公司 |
C1orf32抗体及其用于治疗癌症的用途
|
KR101353930B1
(ko)
|
2012-02-20 |
2014-01-27 |
주식회사 나노엔텍 |
신규한 항원의 검출방법 및 그를 이용한 장치
|
JP6285923B2
(ja)
|
2012-06-22 |
2018-02-28 |
トラスティーズ・オブ・ダートマス・カレッジ |
新規VISTA−Igコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのVISTA−Igの使用
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
EP4119676A1
(de)
|
2012-08-03 |
2023-01-18 |
Foundation Medicine, Inc. |
Menschlicher papillomavirus als prädiktor einer krebsprognose
|
EP2892558B1
(de)
|
2012-09-07 |
2019-04-10 |
The Trustees Of Dartmouth College |
Vista-modulatoren zur diagnose und behandlung von krebs
|
ES2690829T3
(es)
|
2012-09-17 |
2018-11-22 |
Agios Pharmaceuticals, Inc. |
Uso de e-cadherina y vimentina para la selección de pacientes que responden al tratamiento
|
WO2014063205A1
(en)
|
2012-10-26 |
2014-05-01 |
The University Of Queensland |
Use of endocytosis inhibitors and antibodies for cancer therapy
|
WO2014071358A2
(en)
|
2012-11-05 |
2014-05-08 |
Foundation Medicine, Inc. |
Novel ntrk1 fusion molecules and uses thereof
|
KR20150087270A
(ko)
|
2012-11-05 |
2015-07-29 |
프로나이 테라퓨틱스, 인코포레이티드 |
Bcl2 발현 조절에 의한 암치료용 바이오마커 이용 방법
|
SG11201504022RA
(en)
|
2012-11-21 |
2015-06-29 |
Agios Pharmaceuticals Inc |
Glutamase inhibitors and method of use
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
JP6935167B2
(ja)
|
2012-12-21 |
2021-09-15 |
ペルキネルマー ヘルス サイエンシーズ, インコーポレイテッド |
マイクロ流体使用のための低弾性フィルム
|
EP2935908B1
(de)
|
2012-12-21 |
2019-08-14 |
PerkinElmer Health Sciences, Inc. |
Fluidkreisläufe und zugehörige herstellungsverfahren
|
KR20150097764A
(ko)
|
2012-12-21 |
2015-08-26 |
마이크로닉스 인코포레이티드. |
휴대형 형광 검출 시스템 및 미량분석 카트리지
|
EP2938633B1
(de)
|
2012-12-28 |
2018-02-07 |
Precision Biologics, Inc. |
Humanisierte monoklonale antikörper und verfahren zur verwendung zur diagnose und behandlung von darm- und pankreaskrebs
|
WO2014113729A2
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Mecicine, Inc. |
Methods of treating cholangiocarcinoma
|
EP3449977A1
(de)
|
2013-03-15 |
2019-03-06 |
Velo Bio, LLC |
Verfahren zur behandlung von eklampsie und präeklampsie
|
EP2976094B1
(de)
|
2013-03-21 |
2019-08-28 |
The Regents of The University of Michigan |
Verfahren zur behandlung von stoffwechselstörungen
|
WO2014182661A2
(en)
|
2013-05-06 |
2014-11-13 |
Alnylam Pharmaceuticals, Inc |
Dosages and methods for delivering lipid formulated nucleic acid molecules
|
CA2911303C
(en)
|
2013-05-07 |
2021-02-16 |
Micronics, Inc. |
Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
|
US10087440B2
(en)
|
2013-05-07 |
2018-10-02 |
Micronics, Inc. |
Device for preparation and analysis of nucleic acids
|
EP2994750B1
(de)
|
2013-05-07 |
2020-08-12 |
PerkinElmer Health Sciences, Inc. |
Mikrofluidische vorrichtungen und verfahren zur durchführung von serumtrennung und blutkreuzproben
|
EP3004334A4
(de)
|
2013-05-28 |
2016-12-21 |
Biogen Ma Inc |
Verfahren zur beurteilung eines pml-risikos
|
EP3022303B1
(de)
|
2013-07-17 |
2023-11-01 |
Foundation Medicine, Inc. |
Verfahren zur behandlung von urothelialen karzinomen
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
WO2015063604A2
(en)
|
2013-11-01 |
2015-05-07 |
Imberti Luisa |
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNβ AND USES THEREOF
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
KR102344991B1
(ko)
|
2013-12-24 |
2021-12-28 |
잔센파마슈티카엔.브이. |
항-vista 항체 및 단편
|
WO2015131078A1
(en)
|
2014-02-27 |
2015-09-03 |
Biogen Ma Inc. |
Method of assessing risk of pml
|
KR20160127149A
(ko)
|
2014-03-21 |
2016-11-02 |
아지오스 파마슈티컬스 아이엔씨. |
화합물 및 이의 사용 방법
|
WO2015172083A1
(en)
|
2014-05-08 |
2015-11-12 |
Biogen Ma Inc. |
Dimethylfumarate and prodrugs for treatment of multiple sclerosis
|
US20170269075A1
(en)
|
2014-05-12 |
2017-09-21 |
Biogen Ma Inc. |
Biomarkers predictive of lupus progression and uses thereof
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
WO2016026978A1
(en)
|
2014-08-22 |
2016-02-25 |
Universite Nice Sophia Antipolis |
Methods and pharmaceutical compositions for treating drug addiction
|
KR20170068504A
(ko)
|
2014-10-08 |
2017-06-19 |
노파르티스 아게 |
키메라 항원 수용체 요법에 대한 치료 반응성을 예측하는 바이오마커 및 그의 용도
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
US11279768B1
(en)
|
2015-04-03 |
2022-03-22 |
Precision Biologics, Inc. |
Anti-cancer antibodies, combination therapies, and uses thereof
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
CN108780084B
(zh)
|
2015-09-03 |
2022-07-22 |
诺华股份有限公司 |
预测细胞因子释放综合征的生物标志物
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
US11725247B2
(en)
|
2016-02-29 |
2023-08-15 |
Foundation Medicine, Inc. |
Methods of treating cancer
|
KR20170108203A
(ko)
|
2016-03-16 |
2017-09-27 |
주식회사 피플바이오 |
응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
|
EP3448412A4
(de)
|
2016-04-15 |
2020-03-25 |
Immunext Inc. |
Anti-human-vista-antikörper und verwendung davon
|
WO2018013579A1
(en)
|
2016-07-11 |
2018-01-18 |
cARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
Sweat as a biofluid for analysis and disease identification
|
WO2018045162A1
(en)
|
2016-09-01 |
2018-03-08 |
Biogen Ma Inc. |
Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
|
SG11201903913QA
(en)
*
|
2017-01-12 |
2019-05-30 |
Agency Science Tech & Res |
A method of detecting the presence of different target analytes and related kits thereof
|
WO2019237119A1
(en)
|
2018-06-08 |
2019-12-12 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and detection methods for onchocerca volvulus infection
|
WO2020023418A1
(en)
|
2018-07-23 |
2020-01-30 |
Enclear Therapies, Inc. |
Methods of treating neurological disorders
|
CN113164563A
(zh)
|
2018-07-23 |
2021-07-23 |
因柯利尔疗法公司 |
神经性病症的治疗方法
|
WO2020061591A1
(en)
|
2018-09-21 |
2020-03-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins
|
JP7225713B2
(ja)
*
|
2018-11-09 |
2023-02-21 |
東洋紡株式会社 |
抗ストレプトリジンo測定用ラテックス粒子の製造方法
|
AU2020271894A1
(en)
|
2019-04-11 |
2021-12-02 |
Enclear Therapies, Inc. |
Methods of amelioration of cerebrospinal fluid and devices and systems therefor
|